Stempoint Capital reported a 9.9% stake in Cellectar Biosciences CLRB · 845,740 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 9.9%
Last report: First report
Shares held: 845,740 sh
Class: Common stock, par value $0.00001
Stock: Cellectar Biosciences CLRB
Holder: Stempoint Capital
Event date: 26/06/30
Filed: 26/08/14

First 5%+ report · 9.9% stake

Cellectar Biosciences trades, last 26 weeks

What else happened in Cellectar Biosciences around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Stempoint Capital's other 5% stake reports

Stempoint Capital
5% stakeXilio Therapeutics
5% stake
Xilio Therapeutics
XLO
9.5% stake
628,866 sh
9.5% stake
Filed 08/14
Stempoint Capital
5% stakeSurrozen
5% stake
Surrozen
SRZN
5% stake
602,798 sh
5% stake
Filed 08/14
Stempoint Capital
5% stakeFaeth Therapeutics
5% stake
Faeth Therapeutics
FTH
0% stake
0 sh
0% stake
Filed 08/14
Stempoint Capital
5% stakeSurrozen
5% stake
Surrozen
SRZN
4.5% stake
525,639 sh
4.5% stake
Filed 05/15
Stempoint Capital
5% stakeFaeth Therapeutics
5% stake
Faeth Therapeutics
FTH
9.9% stake
132,873 sh
9.9% stake
Filed 05/15

Stempoint Capital reported a 9.9% stake in Cellectar Biosciences CLRB · 845,740 sh · passive holder | Whalegun